Dydrofem Should NOT Be Given During Pregnancy
Dydrofem (estradiol) is absolutely contraindicated during pregnancy and should not be administered at any time during gestation. This is a Pregnancy Category X medication, meaning there is clear evidence of fetal harm 1, 2.
Critical Safety Information
The FDA drug label for products containing estradiol explicitly states:
- Pregnancy Category C for the tetanus-diphtheria formulation (Td), which should only be given "if clearly needed" 2
- Pregnancy Category X for estradiol-containing hormonal products, which are absolutely contraindicated 1
Combined hormonal contraceptives and estrogen-containing products must not be used during pregnancy due to:
- Increased risk of venous thromboembolism
- Potential teratogenic effects
- Cardiovascular complications 3
Specific Contraindications
Estradiol-containing products like those with dydrogesterone are explicitly contraindicated in pregnancy across multiple guidelines 1. The evidence shows:
- Pregnancy is listed as an absolute contraindication for all estradiol/progestin combinations 1
- Recent pharmacovigilance data demonstrates increased reporting of birth defects, particularly hypospadias and congenital heart defects, associated with dydrogesterone exposure during early pregnancy 4
- A disproportionality analysis found significantly higher reporting of birth defects with dydrogesterone (ROR 5.4,95% CI [3.9-7.5]) compared to other drugs 4
Clinical Algorithm
Before prescribing any estradiol-containing product:
- Confirm pregnancy status with urine pregnancy test 1
- If pregnancy test is positive → Do not prescribe
- If pregnancy test is negative → May proceed with appropriate indication
- Counsel patient on contraception needs if sexually active
If inadvertently exposed during pregnancy:
- Discontinue immediately
- Provide appropriate counseling regarding fetal risks
- Consider referral to maternal-fetal medicine for monitoring
Common Pitfall
Do not confuse dydrogesterone (a progestin used in hormone replacement therapy) with progesterone supplementation used in early pregnancy for luteal support in ART cycles. While progesterone has established safety in pregnancy, estradiol-containing products with dydrogesterone are contraindicated 4.
The question of "once or twice" is moot—the answer is zero times during pregnancy.